Brief: Cantargia Publishes Nadunolimab CANFOUR Study Data
26/06/2026 07:06
BRIEF-Cantargia Publishes Nadunolimab CANFOUR Study Data June 26 (Reuters) - Cantargia AB CANTA.ST:
ANNOUNCES PUBLICATION OF NADUNOLIMAB CANFOUR STUDY DATA IN JCI INSIGHT
DATA SUPPORT NADUNOLIMAB POTENTIAL IN FUTURE PANCREATIC CANCER TREATMENT STRATEGIES
SURROGATE ANTIBODY STRONGLY INHIBITS TUMOR GROWTH IN PRECLINICAL PANCREATIC CANCER MODEL
Source text: ID:nMFN9vmqPt
Further company coverage: CANTA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))